×
Entertainment News
Technology News

ads

Saretpa Therapeutics Up 5%, Roth Capital Initiates Coverage

Saretpa Therapeutics Up 5%, Roth Capital Initiates Coverage

Shares of Sarepta Therapeutics (SRPT) climbed more than 5.5% after Roth Capital started coverage with a Buy rating. Roth placed a $52 price target on the stock. In afternoon trade, SRPT was up 5.62% to $32.89.

Saretpa Therapeutics Up 5%, Roth Capital Initiates Coverage

ads